379 related articles for article (PubMed ID: 36085533)
1. Panels of circulating microRNAs as potential diagnostic biomarkers for breast cancer: a systematic review and meta-analysis.
Nguyen THN; Nguyen TTN; Nguyen TTM; Nguyen LHM; Huynh LH; Phan HN; Nguyen HT
Breast Cancer Res Treat; 2022 Nov; 196(1):1-15. PubMed ID: 36085533
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of diagnostic cell-free circulating microRNAs for breast cancer detection.
Sehovic E; Urru S; Chiorino G; Doebler P
BMC Cancer; 2022 Jun; 22(1):634. PubMed ID: 35681127
[TBL] [Abstract][Full Text] [Related]
3. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S
Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526
[TBL] [Abstract][Full Text] [Related]
4. Analysis of circulating microRNA biomarkers for breast cancer detection: a meta-analysis.
Liu L; Wang S; Cao X; Liu J
Tumour Biol; 2014 Dec; 35(12):12245-53. PubMed ID: 25195131
[TBL] [Abstract][Full Text] [Related]
5. The diagnostic role of microRNA-34a in breast cancer: a systematic review and meta-analysis.
Imani S; Zhang X; Hosseinifard H; Fu S; Fu J
Oncotarget; 2017 Apr; 8(14):23177-23187. PubMed ID: 28423566
[TBL] [Abstract][Full Text] [Related]
6. Circulating microRNAs as novel potential diagnostic biomarkers for ovarian cancer: a systematic review and updated meta-analysis.
Wang X; Kong D; Wang C; Ding X; Zhang L; Zhao M; Chen J; Xu X; Hu X; Yang J; Gao S
J Ovarian Res; 2019 Mar; 12(1):24. PubMed ID: 30898156
[TBL] [Abstract][Full Text] [Related]
7. A nine-miRNA signature as a potential diagnostic marker for breast carcinoma: An integrated study of 1,110 cases.
Xiong DD; Lv J; Wei KL; Feng ZB; Chen JT; Liu KC; Chen G; Luo DZ
Oncol Rep; 2017 Jun; 37(6):3297-3304. PubMed ID: 28440475
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-21 as a potential diagnostic biomarker for breast cancer patients: a pooled analysis of individual studies.
Gao Y; Cai Q; Huang Y; Li S; Yang H; Sun L; Chen K; Wang Y
Oncotarget; 2016 Jun; 7(23):34498-506. PubMed ID: 27153564
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA panels as diagnostic biomarkers for colorectal cancer: A systematic review and meta-analysis.
Sur D; Advani S; Braithwaite D
Front Med (Lausanne); 2022; 9():915226. PubMed ID: 36419785
[TBL] [Abstract][Full Text] [Related]
10. A panel of circulating miRNAs as diagnostic biomarkers for screening multiple myeloma: a systematic review and meta-analysis.
Zhang L; Cao D; Tang L; Sun C; Hu Y
Int J Lab Hematol; 2016 Dec; 38(6):589-599. PubMed ID: 27870469
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of circulating microRNAs in thyroid carcinoma: A systematic review and meta-analysis.
Xu SL; Tian YY; Zhou Y; Liu LQ
Clin Endocrinol (Oxf); 2020 Oct; 93(4):489-498. PubMed ID: 32379941
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic significance of circulating miRNAs and metabolite profiling in early prediction of breast cancer in Egyptian women.
El-Toukhy SE; El-Daly SM; Kamel MM; Nabih HK
J Cancer Res Clin Oncol; 2023 Jul; 149(8):5437-5451. PubMed ID: 36459290
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of circulating microRNAs as biomarkers for breast cancer: a meta-analysis study.
Cui Z; Lin D; Song W; Chen M; Li D
Tumour Biol; 2015 Feb; 36(2):829-39. PubMed ID: 25296735
[TBL] [Abstract][Full Text] [Related]
14. Circulating miR-34a and miR-125b as Promising non Invasive Biomarkers in Egyptian Locally Advanced Breast Cancer Patients.
Kassem NM; Makar WS; Kassem HA; Talima S; Tarek M; Hesham H; El-Desouky MA
Asian Pac J Cancer Prev; 2019 Sep; 20(9):2749-2755. PubMed ID: 31554373
[TBL] [Abstract][Full Text] [Related]
15. Assessing the Role of MicroRNAs in Predicting Breast Cancer Recurrence-A Systematic Review.
Bouz Mkabaah L; Davey MG; Lennon JC; Bouz G; Miller N; Kerin MJ
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108278
[TBL] [Abstract][Full Text] [Related]
16. Circulating microRNAs as diagnostic biomarkers for melanoma: a systematic review and meta-analysis.
Wu N; Sun H; Sun Q; Zhang F; Ma L; Hu Y; Cong X
BMC Cancer; 2023 May; 23(1):414. PubMed ID: 37158840
[TBL] [Abstract][Full Text] [Related]
17. A Signature of Four Circulating microRNAs as Potential Biomarkers for Diagnosing Early-Stage Breast Cancer.
Itani MM; Nassar FJ; Tfayli AH; Talhouk RS; Chamandi GK; Itani ARS; Makoukji J; Boustany RN; Hou L; Zgheib NK; Nasr RR
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34204158
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and prognostic value of miR-200 family in breast cancer: A meta-analysis and systematic review.
Thi Chung Duong T; Nguyen THN; Thi Ngoc Nguyen T; Huynh LH; Ngo HP; Thi Nguyen H
Cancer Epidemiol; 2022 Apr; 77():102097. PubMed ID: 35030348
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer.
Bertoli G; Cava C; Castiglioni I
Theranostics; 2015; 5(10):1122-43. PubMed ID: 26199650
[TBL] [Abstract][Full Text] [Related]
20. Exosomal microRNAs as novel diagnostic biomarkers in breast cancer: A systematic evaluation and meta-analysis.
Hong F; Li N; Feng Z; Zheng Y; Zhu C; Zhang F
Asian J Surg; 2023 Nov; 46(11):4727-4736. PubMed ID: 37301624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
